EXPAREL uses proprietary multivesicular liposome (pMVL) technology, an advanced drug delivery platform, to extend analgesia1
DESIGNED
to deliver controlled levels of bupivacaine1
COMPOSED
of naturally occurring, biocompatible lipids2-4
![analgesia](https://d30juwbykjj6mp.cloudfront.net/sites/all/themes/exparel_facility_hcp/images/analgesiaNew.png)
ENCAPSULATES
bupivacaine in a suspension of multivesicular liposomes
RELEASES
bupivacaine over time1
ASP, average sales price; CMS, Centers for Medicare and Medicaid Services.